This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mann, K P Articles by Thorley-Lawson, D A Search for Related Content PubMed PubMed Citation Articles by Mann, K P Articles by Thorley-Lawson, D A

Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

ABSTRACT

We have developed monoclonal antibodies to a 63,000-molecular-weight protein (p63) which is the product of the most abundant messenger RNA in Epstein-Barr virus-transformed cells and shown that the protein is associated specifically with plasma membranes. It was also found to be associated with the other membrane fractions and was found in all Epstein-Barr virus-transformed cells tested. In addition, p63 was present in virions, resulting in transient, early appearance in newly infected cells. Newly synthesized p63 was detected at the time cells underwent blast transformation (48 to 72 h postinfection). The possible role of this protein in transformation and as a target for cell-mediated cytotoxicity is discussed.

This article has been cited by other articles:

• Lin, J.-H., Tsai, C.-H., Chu, J.-S., Chen, J.-Y., Takada, K., Shew, J.-Y. (2007). Dysregulation of HER2/HER3 Signaling Axis in Epstein-Barr Virus-Infected Breast Carcinoma Cells. J. Virol. 81: 5705-5713 [Abstract] [Full Text]  
• Xu, D., Coleman, T., Zhang, J., Fagot, A., Kotalik, C., Zhao, L., Trivedi, P., Jones, C., Zhang, L. (2007). Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas. J. Virol. 81: 6068-6078 [Abstract] [Full Text]  
• Boccellato, F., Anastasiadou, E., Rosato, P., Kempkes, B., Frati, L., Faggioni, A., Trivedi, P. (2007). EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells. J. Virol. 81: 2274-2282 [Abstract] [Full Text]  
• Jimenez-Ramirez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., Sample, C. E. (2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. J. Virol. 80: 11200-11208 [Abstract] [Full Text]  
• Soni, V., Yasui, T., Cahir-McFarland, E., Kieff, E. (2006). LMP1 Transmembrane Domain 1 and 2 (TM1-2) FWLY Mediates Intermolecular Interactions with TM3-6 To Activate NF-{kappa}B. J. Virol. 80: 10787-10793 [Abstract] [Full Text]  
• Spender, L. C., Lucchesi, W., Bodelon, G., Bilancio, A., Karstegl, C. E., Asano, T., Dittrich-Breiholz, O., Kracht, M., Vanhaesebroeck, B., Farrell, P. J. (2006). Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55{alpha} regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.. J. Gen. Virol. 87: 2859-2867 [Abstract] [Full Text]  
• Chen, A., Zhao, B., Kieff, E., Aster, J. C., Wang, F. (2006). EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines.. J. Virol. 80: 10139-10150 [Abstract] [Full Text]  
• Stevenson, D., Charalambous, C., Wilson, J. B. (2005). Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9. Cancer Res. 65: 8826-8835 [Abstract] [Full Text]  
• Lu, K. T., Dryer, R. L., Song, C., Covey, L. R. (2005). Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV. J. Leukoc. Biol. 78: 620-629 [Abstract] [Full Text]  
• Kotsiopriftis, M., Tanner, J. E., Alfieri, C. (2005). Heat Shock Protein 90 Expression in Epstein-Barr Virus-Infected B Cells Promotes {gamma}{delta} T-Cell Proliferation In Vitro. J. Virol. 79: 7255-7261 [Abstract] [Full Text]  
• Ahsan, N., Kanda, T., Nagashima, K., Takada, K. (2005). Epstein-Barr Virus Transforming Protein LMP1 Plays a Critical Role in Virus Production. J. Virol. 79: 4415-4424 [Abstract] [Full Text]  
• Peng, R., Moses, S. C., Tan, J., Kremmer, E., Ling, P. D. (2005). The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter. J. Virol. 79: 4492-4505 [Abstract] [Full Text]  
• Chen, A., DiVisconte, M., Jiang, X., Quink, C., Wang, F. (2005). Epstein-Barr Virus with the Latent Infection Nuclear Antigen 3B Completely Deleted Is Still Competent for B-Cell Growth Transformation In Vitro. J. Virol. 79: 4506-4509 [Abstract] [Full Text]  
• Chang, Y., Lee, H.-H., Chang, S.-S., Hsu, T.-Y., Wang, P.-W., Chang, Y.-S., Takada, K., Tsai, C.-H. (2004). Induction of Epstein-Barr Virus Latent Membrane Protein 1 by a Lytic Transactivator Rta. J. Virol. 78: 13028-13036 [Abstract] [Full Text]  
• Lee, J. M., Lee, K.-H., Farrell, C. J., Ling, P. D., Kempkes, B., Park, J. H., Hayward, S. D. (2004). EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic Stimuli. J. Virol. 78: 12694-12697 [Abstract] [Full Text]  
• Yasui, T., Luftig, M., Soni, V., Kieff, E. (2004). Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101: 278-283 [Abstract] [Full Text]  
• Huang, J., Chen, H., Hutt-Fletcher, L., Ambinder, R. F., Hayward, S. D. (2003). Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer. J. Virol. 77: 13267-13274 [Abstract] [Full Text]  
• Vazirabadi, G., Geiger, T. R., Coffin, III, W. F., Martin, J. M. (2003). Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 84: 1997-2008 [Abstract] [Full Text]  
• Moody, C. A., Scott, R. S., Su, T., Sixbey, J. W. (2003). Length of Epstein-Barr Virus Termini as a Determinant of Epithelial Cell Clonal Emergence. J. Virol. 77: 8555-8561 [Abstract] [Full Text]  
• Flanagan, J., Middeldorp, J., Sculley, T. (2003). Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 84: 1871-1879 [Abstract] [Full Text]  
• Imadome, K.-I., Shirakata, M., Shimizu, N., Nonoyama, S., Yamanashi, Y. (2003). CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc. Natl. Acad. Sci. USA 100: 7836-7840 [Abstract] [Full Text]  
• Chen, H., Hutt-Fletcher, L., Cao, L., Hayward, S. D. (2003). A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus. J. Virol. 77: 4139-4148 [Abstract] [Full Text]  
• Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., Kieff, E. (2002). EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth. J. Virol. 77: 999-1010 [Abstract] [Full Text]  
• Chung, P.-J., Chang, Y.-S., Liang, C.-L., Meng, C.-L. (2002). Negative Regulation of Epstein-Barr Virus Latent Membrane Protein 1-mediated Functions by the Bone Morphogenetic Protein Receptor IA-binding Protein, BRAM1. J. Biol. Chem. 277: 39850-39857 [Abstract] [Full Text]  
• Binne, U. K., Amon, W., Farrell, P. J. (2002). Promoter Sequences Required for Reactivation of Epstein-Barr Virus from Latency. J. Virol. 76: 10282-10289 [Abstract] [Full Text]  
• Gordadze, A. V., Poston, D., Ling, P. D. (2002). The EBNA2 Polyproline Region Is Dispensable for Epstein-Barr Virus-Mediated Immortalization Maintenance. J. Virol. 76: 7349-7355 [Abstract] [Full Text]  
• Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J. (2002). Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype. J. Virol. 76: 4919-4927 [Abstract] [Full Text]  
• Voss, M. D., Hille, A., Barth, S., Spurk, A., Hennrich, F., Holzer, D., Mueller-Lantzsch, N., Kremmer, E., Grasser, F. A. (2001). Functional Cooperation of Epstein-Barr Virus Nuclear Antigen 2 and the Survival Motor Neuron Protein in Transactivation of the Viral LMP1 Promoter. J. Virol. 75: 11781-11790 [Abstract] [Full Text]  
• Spender, L. C., Cornish, G. H., Rowland, B., Kempkes, B., Farrell, P. J. (2001). Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection. J. Virol. 75: 3537-3546 [Abstract] [Full Text]  
• Higuchi, M., Izumi, K. M., Kieff, E. (2001). Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 98: 4675-4680 [Abstract] [Full Text]  
• Peng, R., Tan, J., Ling, P. D. (2000). Conserved Regions in the Epstein-Barr Virus Leader Protein Define Distinct Domains Required for Nuclear Localization and Transcriptional Cooperation with EBNA2. J. Virol. 74: 9953-9963 [Abstract] [Full Text]  
• Inman, G. J., Allday, M. J. (2000). Resistance to TGF-{beta}1 correlates with a reduction of TGF-{beta} type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. J. Gen. Virol. 81: 1567-1578 [Abstract] [Full Text]  
• Xu, J., Ahmad, A., D'Addario, M., Knafo, L., Jones, J. F., Prasad, U., Dolcetti, R., Vaccher, E., Menezes, J. (2000). Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases. J. Immunol. 164: 2815-2822 [Abstract] [Full Text]  
• Wade, M., Allday, M. J. (2000). Epstein-Barr Virus Suppresses a G2/M Checkpoint Activated by Genotoxins. Mol. Cell. Biol. 20: 1344-1360 [Abstract] [Full Text]  
• Zhang, L., Pagano, J. S. (2000). Interferon Regulatory Factor 7 Is Induced by Epstein-Barr Virus Latent Membrane Protein 1. J. Virol. 74: 1061-1068 [Abstract] [Full Text]  
• Jenkins, P. J., Binné, U. K., Farrell, P. J. (2000). Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency. J. Virol. 74: 710-720 [Abstract] [Full Text]  
• Aguirre, A. J., Robertson, E. S. (2000). Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus. J. Virol. 74: 735-743 [Abstract] [Full Text]  
• Yang, X., Sham, J. S. T., Ng, M. H., Tsao, S.-W., Zhang, D., Lowe, S. W., Cao, L. (2000). LMP1 of Epstein-Barr Virus Induces Proliferation of Primary Mouse Embryonic Fibroblasts and Cooperatively Transforms the Cells with a p16-Insensitive CDK4 Oncogene. J. Virol. 74: 883-891 [Abstract] [Full Text]  
• Erickson, K. D., Martin, J. M. (2000). The Late Lytic LMP-1 Protein of Epstein-Barr Virus Can Negatively Regulate LMP-1 Signaling. J. Virol. 74: 1057-1060 [Abstract] [Full Text]  
• Bloss, T., Kaykas, A., Sugden, B. (1999). Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-{kappa}B activity. J. Gen. Virol. 80: 3227-3232 [Abstract] [Full Text]  
• Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., Kieff, E. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. J. Virol. 73: 10525-10530 [Abstract] [Full Text]  
• Spender, L. C., Cannell, E. J., Hollyoake, M., Wensing, B., Gawn, J. M., Brimmell, M., Packham, G., Farrell, P. J. (1999). Control of Cell Cycle Entry and Apoptosis in B Lymphocytes Infected by Epstein-Barr Virus. J. Virol. 73: 4678-4688 [Abstract] [Full Text]  
• Fujiwara, S., Nitadori, Y., Nakamura, H., Nagaishi, T., Ono, Y. (1999). Epstein-Barr Virus (EBV) Nuclear Protein 2-Induced Disruption of EBV Latency in the Burkitt's Lymphoma Cell Line Akata: Analysis by Tetracycline-Regulated Expression. J. Virol. 73: 5214-5219 [Abstract] [Full Text]  
• Fingeroth, J. D., Diamond, M. E., Sage, D. R., Hayman, J., Yates, J. L. (1999). CD21-Dependent Infection of an Epithelial Cell Line, 293, by Epstein-Barr Virus. J. Virol. 73: 2115-2125 [Abstract] [Full Text]  
• Ruf, I. K., Rhyne, P. W., Yang, H., Borza, C. M., Hutt-Fletcher, L. M., Cleveland, J. L., Sample, J. T. (1999). Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma. Mol. Cell. Biol. 19: 1651-1660 [Abstract] [Full Text]  
• Harada, S., Yalamanchili, R., Kieff, E. (1998). Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation. J. Virol. 72: 9948-9954 [Abstract] [Full Text]  
• Johnson, R. J., Stack, M., Hazlewood, S. A., Jones, M., Blackmore, C. G., Hu, L.-F., Rowe, M. (1998). The 30-Base-Pair Deletion in Chinese Variants of the Epstein-Barr Virus LMP1 Gene Is Not the Major Effector of Functional Differences between Variant LMP1 Genes in Human Lymphocytes. J. Virol. 72: 4038-4048 [Abstract] [Full Text]  
• Frisan, T., Levitsky, V., Polack, A., Masucci, M. G. (1998). Phenotype-Dependent Differences in Proteasome Subunit Composition and Cleavage Specificity in B Cell Lines. J. Immunol. 160: 3281-3289 [Abstract] [Full Text]  
• Sjoblom, A., Yang, W., Palmqvist, L., Jansson, A., Rymo, L. (1998). An ATF/CRE Element Mediates both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter. J. Virol. 72: 1365-1376 [Abstract] [Full Text]  
• Izumi, K. M., Kaye, K. M., Kieff, E. D. (1997). The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94: 1447-1452 [Abstract] [Full Text]  
• Aviel, S., Winberg, G., Massucci, M., Ciechanover, A. (2000). Degradation of the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) by the Ubiquitin-Proteasome Pathway. TARGETING VIA UBIQUITINATION OF THE N-TERMINAL RESIDUE. J. Biol. Chem. 275: 23491-23499 [Abstract] [Full Text]